Geron
GERN
$4.08
Share price
3.82%
Change (1 day)
59.38%
Change (1 year)
Categories
Geron (GERN) Fails to deliver data
Key failure to deliver metrics for Geron:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $1.2 M
- Last 3 months FTD volume: $10.86 M
- Last year FTD volume: $15.05 M
Failures to deliver for Geron (GERN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Geron (GERN) - since 2013
Volume in USD (price x number of shares), data since 2013Geron (GERN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $11.1 M | 49.61% |
| 2023 | $7.41 M | 6.85% |
| 2022 | $6.94 M | -29.22% |
| 2021 | $9.81 M | -1.1% |
| 2020 | $9.92 M | -59.12% |
| 2019 | $24.26 M | -92.08% |
| 2018 | $0.30 B | 7255.69% |
| 2017 | $4.16 M | -75.13% |
| 2016 | $16.74 M | 37.77% |
| 2015 | $12.15 M | -47.43% |
| 2014 | $23.11 M | 1097.28% |
| 2013 | $1.93 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Gilead Sciences GILD | $32.63 M | $0.25 B | 🇺🇸 USA |
 Incyte INCY | $81.59 M | $0.10 B | 🇺🇸 USA |
 CTI BioPharma
CTIC | N/A | $44.66 M | 🇺🇸 USA |
 Bio-Techne TECH | $11.63 M | $29.65 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.04 M | $0.25 M | 🇺🇸 USA |